Advertisement

Organisation › Details
Roche Tissue Diagnostics (RTD)
![]() |
Start | 2024-02-13 existent |
Group | Roche (Group) | |
![]() |
Industry | diagnostics (medical/biological) |
Industry 2 | pathology | |
City | n. a. | |
Address record changed: 2024-02-26 | ||
Basic data | Employees | n. a. |
Record changed: 2024-02-26 |
Advertisement

More documents for Roche (Group)
- [1] Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou....
- [2] Roche. (12/18/24). "Press Release: Roche Transforms Mass Spectrometry Diagnostics with Launch of cobas Mass Spec Solution". Basel....
- [3] Roche. (11/26/24). "Press Release: Roche Enters into a Definitive Agreement to Acquire Poseida Therapeutics, Including Cell Therapy Candidates and Related Platform technologies". Basel....
- [4] Regor Pharmaceuticals (USA). (9/30/24). "Press Release: Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of Next-generation CDK Inhibitors for the Treatment of Breast Cancer". Cambridge, MA....
- [5] Roche. (9/10/24). "Press Release: Roche Opens Pharma Research and Development Center in Basel to Accelerate Scientific Innovation". Basel....
- [6] Sangamo Therapeutics, Inc.. (8/6/24). "Press Release: Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases". Richmond, CA....
- [7] Immunic, Inc.. (7/24/24). "Press Release: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec". New York, NY....
- [8] Haya Therapeutics SA. (7/18/24). "Press Release: Haya Therapeutics Appoints Former Roche Global Head of Operations Eric Adam, Ph.D. as Chief Operating Officer". Lausanne & San Diego, CA....
- [9] Hitachi High-Tech Corporation. (5/27/24). "Press Release: Roche and Hitachi High-Tech Extend Their Long-standing Partnership". Tokyo....
- [10] Pfizer Inc.. (4/26/24). "Press Release: U.S. FDA Approves Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B". New York, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top